Insider · CIK 0001714982
Oltmans Curtis Gale
Reports to the SEC for 3 companies · CAMBRIDGE, MA
Transactions
36
Companies
3
Filings
16
CIK
0001714982
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-02-02 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-12-15 | FULCFulcrum Therapeutics, Inc.S Sale | −$44.6K |
| 2025-01-24 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-09-23 | ATXIAVENUE THERAPEUTICS, INC. · Employee stock option (right to buy)A Award | — |
| 2024-01-26 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-30 | ATXIAVENUE THERAPEUTICS, INC. · Employee stock option (right to buy)A Award | — |
| 2023-04-26 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-02-09 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-08-09 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-01-19 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2021-12-17 | FULCFulcrum Therapeutics, Inc.G Gift | — |
| 2021-12-17 | ATXIAVENUE THERAPEUTICS, INC.A Award | — |
| 2021-06-28 | FULCFulcrum Therapeutics, Inc.P Purchase | +$9,802.88 |
| 2020-12-03 | FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2019-02-05 | ARRAY BIOPHARMA INCM Exercise/Conversion | +$358K |
| 2019-02-05 | ARRAY BIOPHARMA INCS Sale | −$800K |
| 2019-02-05 | ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-01-29 | ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-01-29 | ARRAY BIOPHARMA INCM Exercise/Conversion | +$99.2K |
| 2019-01-25 | ARRAY BIOPHARMA INCM Exercise/Conversion | +$125K |
| 2019-01-25 | ARRAY BIOPHARMA INCS Sale | −$253K |
| 2019-01-25 | ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-01-18 | ARRAY BIOPHARMA INCM Exercise/Conversion | +$11.2K |
| 2019-01-18 | ARRAY BIOPHARMA INCS Sale | −$22.5K |
| 2019-01-18 | ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2019-01-15 | ARRAY BIOPHARMA INCM Exercise/Conversion | +$176K |
| 2019-01-15 | ARRAY BIOPHARMA INCS Sale | −$356K |
| 2019-01-15 | ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion | — |
| 2018-12-16 | ARRAY BIOPHARMA INCM Exercise/Conversion | — |
| 2018-12-16 | ARRAY BIOPHARMA INCF Tax Payment | −$49.2K |
| 2018-12-16 | ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion | — |
| 2018-12-14 | ARRAY BIOPHARMA INCRestricted Stock UnitsA Award | — |
| 2018-12-14 | ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award | — |
| 2017-12-16 | ARRAY BIOPHARMA INCRestricted Stock UnitsA Award | — |
| 2017-12-16 | ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award | — |
| 2017-08-15 | ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award | — |
Recent filings
- 4Oltmans Curtis Gale0001193125-26-037576SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001193125-25-322740SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000950170-25-009813SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001104659-24-102837SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000950170-24-009092SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001104659-23-078090SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000950170-23-015824SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000899243-23-004745SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000899243-22-028368SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000899243-22-002877SEC(opens sec.gov)
- 5Oltmans Curtis Gale0000899243-22-001356SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001104659-21-152195SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000899243-21-026556SEC(opens sec.gov)
- 4Oltmans Curtis Gale0000899243-20-032867SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001562180-19-000816SEC(opens sec.gov)
- 4Oltmans Curtis Gale0001562180-19-000564SEC(opens sec.gov)
Companies
Address
C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET
CAMBRIDGE, MA, 02139